| Report | Options implied | Actual move | Market was |
|---|---|---|---|
| 08/06/2026 | ±4.7% | -1.7% | over-priced |
| 05/08/2026 | ±3.8% | +1.7% | over-priced |
| 11/06/2025 | ±3.6% | -3.9% | under-priced |
| 08/08/2025 | ±2.4% | +2.6% | under-priced |
| 05/08/2025 | ±3.0% | +1.2% | over-priced |
| 11/08/2024 | ±3.1% | -4.6% | under-priced |
| 08/07/2024 | ±5.5% | -3.7% | over-priced |
| 05/08/2024 | ±2.8% | -2.8% | over-priced |
| Quarter | EPS (dil.) | Revenue | Net income |
|---|---|---|---|
| Q2 FY2026 | $0.68 | $7.0B | $1.4B |
| Q1 FY2026 | $0.61 | $6.2B | $1.4B |
| Q4 FY2025 | — | $5.6B | $565M |
| Q3 FY2025 | $0.46 | $7.0B | $1.2B |
Freeport-McMoran Inc. (FCX) reports in 76 days, with the next report estimated for 11/27/2026. Across the last 8 reports, options priced an average ±3.6% earnings move while the stock actually moved 2.8% on average — the market has been roughly fair on FCX's earnings risk. Fundamentals into the print: EPS up 28.3% year-over-year, revenue down 7.3%. QuantLogix's live 5-factor engine currently reads FCX as a buy at 61/100.
Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →